BioMed Research International / 2017 / Article / Tab 2

Research Article

A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy

Table 2

Locations of metastases and responses after two courses of GN therapy.

CR⋅PRSDPDTotal

Lymph node13 (59%)7222
Lung4 (57%)127
Liver2 (67%)103
Bone0 (0.0%)202
Local recurrence1 (17%)506
Urethra0 (0.0%)101